Find clinical trials for multiple sclerosis. Search for multiple sclerosis clinical trials in different cities and states across the United States.
Multiple sclerosis (MS) clinical trials are research studies that test new ways to treat, manage, or prevent MS. These trials are essential for developing new medications, therapies, and strategies to improve the quality of life for individuals living with MS. They range from early-stage research, testing the safety and efficacy of new treatments, to later-stage trials that compare new treatments to current standards.
Clinical trials are fundamental to MS research as they provide the scientific basis for developing new treatments and understanding the disease better. Through these trials, researchers can evaluate the effectiveness of new drugs, therapies, and management strategies, ensuring that only the most effective treatments are approved for general use. Clinical trials also help in identifying the causes of MS and factors that influence disease progression.
Multiple sclerosis (MS) clinical trials encompass a range of studies, each targeting different aspects of this neurological condition. They range from exploring new medications and therapies aimed at managing symptoms and altering the disease's course, to prevention strategies and rehabilitation methods to enhance the quality of life for those affected.
Treatment trials in MS focus on finding new medications or treatment strategies to manage the symptoms of MS. These include trials for drugs that can effectively manage symptoms of MS, reduce the frequency and severity of relapses, and slow the progression of the disease.
Prevention trials aim to identify strategies that could prevent MS or delay its progression in individuals who are at high risk or in the early stages of the disease. These studies might involve lifestyle changes, medications, or other interventions that could potentially prevent the onset or reduce the progression of MS.
Rehabilitation trials research ways to improve daily functioning and quality of life for those diagnosed with MS. These trials might test physical therapy programs, cognitive rehabilitation techniques, or novel assistive technologies designed to help manage the symptoms of MS.
These trials explore the potential of new and emerging therapies in MS treatment, such as stem cell therapy, neuroprotective strategies, and novel immunotherapies. The goal is to find breakthrough treatments that can significantly alter the course of MS.
Eligibility for MS clinical trials varies depending on the study's focus. Generally, these trials are open to individuals who have been diagnosed with MS, though specific criteria like the type of MS, the stage of the disease, and overall health will vary. Some trials may also be open to healthy volunteers without MS for preventative studies.
When joining an MS clinical trial, participants can expect to go through a detailed consent process, where they will be informed about the purpose of the study, the procedures involved, potential risks and benefits, and their rights as participants. Participants will undergo initial evaluations and be closely monitored throughout the study for any changes in their condition. Regular follow-ups and assessments are usually part of the process to ensure the effectiveness of the treatment being studied.
Worried about the risks of participating in a clinical trial? Delve into our comprehensive guide to gain insights into the potential outcomes of participating. Learn about potential risks, benefits, and safety considerations to make an informed decision about your participation in a clinical trial.
Enrolling in an MS clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
Sponsor:
Biogen
Location:
Code:
NCT05798520
Conditions
Relapsing Forms of Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
BIIB091
DRF
Placebo
Sponsor:
Jazz Pharmaceuticals
Location:
Code:
NCT05864846
Conditions
Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
Eligibility Criteria
Sex: All
Age: 1 - 65
Healthy Volunteers: Not accepted
Interventions
Cannabidiol Oral Solution [Epidiolex]
Sponsor:
Jazz Pharmaceuticals
Location:
Code:
NCT04485104
Conditions
Seizure in Participants With Tuberous Sclerosis Complex
Seizure in Participants With Dravet Syndrome
Seizure in Participants With Lennox-Gastaut Syndrome
Eligibility Criteria
Sex: All
Age: 1 - 23
Healthy Volunteers: Not accepted
Interventions
GWP42003-P
Sponsor:
Joanne Kurtzberg, MD
Location:
Code:
NCT04943289
Conditions
Primary Progressive Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
DUOC-01
Sponsor:
University of Kansas Medical Center
Location:
Code:
NCT03969927
Conditions
Parkinson Disease
Multiple Sclerosis
Stroke
Eligibility Criteria
Sex: All
Age: 25 - 70+
Healthy Volunteers: Not accepted
Interventions
Low-Fidelity PDS
High Fidelity Fixed-Base Simulator
Sponsor:
The University of Texas Health Science Center, Houston
Location:
Code:
NCT05888727
Conditions
Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Seated Physical activity INtervention for persons with MS, "SPIN" program- Intervention Condition
WEllness for Longevity Living with MS (WELL)- Control Condition
Sponsor:
Sanofi
Location:
Code:
NCT06141473
Conditions
Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Not accepted
Interventions
Frexalimab
Teriflunomide
Placebo infusion
Placebo tablet
MRI contrast-enhancing agents